{"url_path":"/sec/rytm/8-k/2026-06-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1649904/0001628280-26-043170-index.html","accession_number":"0001628280-26-043170","cik":"0001649904","ticker":"RYTM","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649904/0001628280-26-043170-index.html","primary_entity_key":"0001649904","primary_entity_name":"RHYTHM PHARMACEUTICALS, INC."},"word_count":104,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\nThe following Exhibits 99.1, 99.2 and 99.3 shall be deemed to be furnished and not filed.\n\nExhibit\nNo.Description\n\n99.1\n[Press release dated June 13, 2026](ex991rytmprpwsatendo2026.htm)\n\n99.2\n[Presentation dated June 13, 2026](ex992pwsatendo2026.htm)\n\n99.3\n[Press release dated June 15, 2026](ex993rytmendorecappr2.htm)\n\n104Cover Page Interactive Data File (embedded within the inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nRHYTHM PHARMACEUTICALS, INC.\n\nDate: June 15, 2026By:/s/ Hunter Smith\n\nHunter Smith\n\nChief Financial Officer"}